BIOLINERX     Print Page  Close Window

SEC filings
6-K
BIOLINERX LTD. filed this Form 6-K on 03/10/2016
Entire Document
 
 

 
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
 
BioLineRx Ltd.
 
 
  By:
/s/ Philip Serlin
 
   
Philip Serlin
 
   
Chief Financial and Operating Officer
 
 
Dated: March 10, 2016